| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.4 | 0.0009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |